Mahya Sheikhzadeh v. HHS - Influenza, shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On April 24, 2024, Mahya Sheikhzadeh filed a petition alleging a shoulder injury related to vaccine administration after vaccinations on December 8, 2022. The stipulation identifies an influenza vaccine as the Vaccine Program claim and notes that a COVID-19 vaccine was administered concurrently; Ms.
Sheikhzadeh waived any COVID-19-related claim within this case. Respondent denied that Ms.
Sheikhzadeh sustained a Table SIRVA, denied that the flu vaccine caused her alleged shoulder injury or any other injury, and denied that her current condition was vaccine related. The public decision is limited to the stipulation and does not describe onset, medical treatment, imaging, physical therapy, or functional limitations.
Chief Special Master Brian H. Corcoran adopted the parties' stipulation on September 24, 2025.
Ms. Sheikhzadeh was awarded a lump sum of $36,131.00 through counsel's IOLTA account for all Vaccine Act damages.
She was represented by Bridget Candace McCullough of Muller Brazil, LLP.
Theory of causation
Influenza vaccine with concurrent COVID-19 vaccine, December 8, 2022, adult inferred, alleged SIRVA from flu vaccine; COVID-19 claim waived to avoid CICP conflict. COMPENSATED by stipulation. Respondent denied Table SIRVA, flu causation, and current sequelae. Public stipulation gives no onset/treatment/imaging details. Award: $36,131 lump sum by ACH to counsel IOLTA for all Section 15(a) damages. Chief Special Master Corcoran September 24, 2025. Attorney Bridget Candace McCullough; respondent Lauren Kells.
Source PDFs
USCOURTS-cofc-1_24-vv-00650